Fin Trust Capital Advisors, LLC Astrazeneca PLC Transaction History

Fin Trust Capital Advisors, LLC

$577 Million
Q3 2024

A detailed history of Fin Trust Capital Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 11,200 shares of AZN stock, worth $721,728. This represents 0.15% of its overall portfolio holdings.

Number of Shares

11,200

Previous 10,696 4.71%

Holding current value

$721,728

Previous $834,000 4.56%

% of portfolio

0.15%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$76.67 - $87.62 $38,641 - $44,160	504 Added 4.71%	11,200 $872,000
Q2 2024 Jul 24, 2024	BUY	$66.81 - $80.83 $138,497 - $167,560	2,073 Added 24.04%	10,696 $834,000
Q1 2024 May 02, 2024	BUY	$61.03 - $69.57 $3,661 - $4,174	60 Added 0.7%	8,623 $584,000
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $41,218 - $46,140	-666 Reduced 7.22%	8,563 $576,000
Q3 2023 Oct 24, 2023	SELL	$64.85 - $71.7 $223,343 - $246,934	-3,444 Reduced 27.18%	9,229 $624,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $181,820 - $236,255	3,354 Added 35.99%	12,673 $859,000
Q3 2022 Oct 20, 2022	BUY	$53.02 - $135.75 $210,595 - $539,199	3,972 Added 74.28%	9,319 $511,000
Q2 2022 Jul 26, 2022	SELL	$59.26 - $71.14 $770 - $924	-13 Reduced 0.24%	5,347 $353,000
Q1 2022 May 03, 2022	BUY	$55.72 - $67.12 $278,600 - $335,600	5,000 Added 1388.89%	5,360 $355,000
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $7,000 - $7,659	126 Added 53.85%	360 $22,000
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $1,888 - $2,347	39 Added 20.0%	234 $14,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $5,470 - $6,315	116 Added 146.84%	195 $10,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $1,989 - $2,378	41 Added 107.89%	79 $4,000
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $5,094 - $5,865	-96 Reduced 71.64%	38 $2,000
Q2 2020 Sep 11, 2020	BUY	$43.1 - $55.31 $5,775 - $7,411	134 New	134 $7,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $9,482 - $12,168	-220 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $718 - $975	-19 Reduced 7.95%	220 $10,000
Q4 2019 Jan 23, 2020	SELL	$42.46 - $50.46 $1,358 - $1,614	-32 Reduced 11.81%	239 $12,000
Q3 2019 Oct 29, 2019	SELL	$40.12 - $45.47 $5,697 - $6,456	-142 Reduced 34.38%	271 $12,000
Q2 2019 Aug 01, 2019	SELL	$37.28 - $41.68 $11,929 - $13,337	-320 Reduced 43.66%	413 $17,000
Q1 2019 May 09, 2019	BUY	$35.49 - $43.02 $248 - $301	7 Added 0.96%	733 $30,000
Q4 2018 Feb 11, 2019	BUY	$36.86 - $41.49 $26,760 - $30,121	726 New	726 $28,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Account

Fin Trust Capital Advisors, LLC Astrazeneca PLC Transaction History